Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
about
sameAs
The pharmacokinetics and pharmacodynamics of the carbapanemes: focus on doripenemCyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patientsDisposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteriaEffects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.Melamine-induced renal toxicity is mediated by the gut microbiota.Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospitalUse of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.Ertapenem: review of a new carbapenem.Pharmacological aspects of the antibiotics used for urological diagnostic procedures.Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.Imipenem-cilastatin induced pure white cell aplasia.Pharmacokinetics and pharmacodynamic assessment of imipenem in the intraperitoneal fluid of abdominal surgery patients.Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.
P2860
Q28289744-973BEF70-3993-4FC2-8A37-CD007A3AB407Q28368201-5A2FAD9A-37E2-4878-B935-9C12DA55C920Q33694884-C25C25F8-DA7D-4841-A6F0-FCCE3C7C57DFQ33696946-2D97E5ED-444D-4A1F-BFAE-EBBE0E6A8E52Q33977810-12522F35-116E-4A57-B761-E1CCE84CA1B3Q34327763-807A8D90-BCE1-4E69-9B01-BF131B40D6B3Q35229009-A16C4302-81C7-4487-8049-06887229C700Q36018937-66D6A6DD-530F-4944-AF77-5B5C4BD6065CQ36066200-2C27016E-DB5A-4303-A9C7-261E7B222154Q38253258-F10FB6EF-18EA-473C-8AF7-C263E5C07C31Q39652013-2C23DF0F-0016-49EF-82D5-56F75CD42798Q39781204-E1342EB6-1355-4BE5-82D6-124DC06674A9Q46683515-58255E59-CD37-40CA-B0EA-33871EECC74FQ46731345-F30C2FE5-8AB8-4178-86DA-9A72E48ECA29Q47106329-36CFB532-6830-4210-92AD-94F987AA5270Q47647577-8F8C486D-BB0E-4FF7-9621-3DACEE932FAE
P2860
Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@ast
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@en
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@nl
type
label
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@ast
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@en
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@nl
altLabel
Imipenem/Cilastatin : A Reappr ...... ties and Therapeutic Efficacy.
@en
Imipenem/Cilastatin : A Reappr ...... ties and Therapeutic Efficacy.
@nl
prefLabel
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@ast
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@en
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@nl
P2093
P1433
P1476
Imipenem/Cilastatin : A Reappr ...... ties and Therapeutic Efficacy.
@en
Imipenem/cilastatin. A reappra ...... rties and therapeutic efficacy
@en
P2093
Karen L Goa
L B Barradell
Lee B Barradell
M M Buckley
Micaela M Buckley
P356
10.2165/00003495-199244030-00008
P407
P577
1992-09-01T00:00:00Z
P6179
1002835887